Mm, the continuing slide is a concern, I agree. Thing is, though, the average daily volume over the past three months is 243,000 shares. That's only $24k worth (and today's is only around $43k worth) ... I'm no expert, but that looks to me more like a bit of a holding pattern than a serious rush for the exits.
If funding came through tomorrow, we'd see a big rise, there's no two ways about that. It probably won't though. When (if!) it will happen - that's the four hundred million dollar question.
It's basically a gamble. We (should) all know that. I'm still hanging on, hoping that the money comes through sometime this year - that the economics of the mine (which still look pretty good to my untrained eye, even with the drop in rare earth prices) will win through. Should you? Well, it comes down to the advice my father gave me: don't put money into the share market that you can't afford to lose.
- Forums
- ASX - By Stock
- PEK
- scoping study numbers out dated
PEK
peak rare earths limited
Add to My Watchlist
0.00%
!
30.0¢

scoping study numbers out dated, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.1M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 29.5¢ | $2.578M | 8.593M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 388491 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 350216 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 388491 | 0.295 |
16 | 1350762 | 0.290 |
17 | 686552 | 0.285 |
4 | 209429 | 0.280 |
2 | 137000 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 350216 | 4 |
0.305 | 154185 | 5 |
0.310 | 233210 | 6 |
0.315 | 199219 | 4 |
0.320 | 185423 | 7 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online